Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients - Wikidata - awgldk - TriplyDB

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

http://www.wikidata.org/entity/Q27473044

about

Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus New perspectives in occult hepatitis C virus infection Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins Role for TBC1D20 and Rab1 in hepatitis C virus replication via interaction with lipid droplet-bound nonstructural protein 5A Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122 Hepatitis C virus hijacks host lipid metabolism Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I Hepatitis C virus relies on lipoproteins for its life cycle Status of hepatitis C virus vaccination: Recent update Chronic hepatitis C virus infection and lipoprotein metabolism Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization Neutralizing antibody response to hepatitis C virus ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production Spatiotemporal analysis of hepatitis C virus infection Molecular determinants and dynamics of hepatitis C virus secretion Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles Hepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic Cell Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells Ultracentrifugation of Serum Samples Allows Detection of Hepatitis C Virus RNA in Patients with Occult Hepatitis C Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion Th1 Disabled Function in Response to TLR4 Stimulation of Monocyte-Derived DC from Patients Chronically-Infected by Hepatitis C Virus Binding of liver derived, low density hepatitis C virus to human hepatoma cells Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity Apolipoprotein C1 Association with Hepatitis C Virus Characterization of hepatitis C RNA-containing particles from human liver by density and size Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies In vitro selection of a neutralization-resistant hepatitis C virus escape mutant Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins Targeting host factors: A novel rationale for the management of hepatitis C virus Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles Hepatitis C Virus entry: the early steps in the viral replication cycle Do statins reduce hepatitis C RNA titers during routine clinical use?Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis

P2860

Q21090530-AB7E4250-8880-4EB7-A839-1A5C16793311 Q22305491-6E90EF4D-B48F-4058-8EF8-819D1A89996C Q24301976-1EAD6059-C115-47B1-BC38-4BA8A07731B0 Q24312182-B1649C6A-F815-4644-BDBE-B740591FFE1E Q24609988-0A79C2E6-1140-4B07-B7D7-AA5139945D7C Q24652319-C4337203-8C9C-4E41-9173-30F12E6978A8 Q24672232-A7F28D87-7382-4229-BA4D-E502CAEBB997 Q24676039-D2D09625-CD72-47E6-A84B-BC8F857E43DB Q26766119-C45E09E1-8A03-4C12-A324-8C549DAD1ED4 Q26774612-0620D5FF-EBE4-4260-9D26-AC5CE9AF3B18 Q26784234-C9A381FE-0D4B-4CC0-A9ED-16334D8C623C Q26801759-B49BB74C-C2C2-4FEA-9EB3-29806C669C07 Q26864485-DD027B2E-D2EF-4E23-AF94-ECFA86519489 Q27027484-501AF97C-A7F3-4F04-B04A-D17292EDBCD1 Q27314827-48A633CF-00BD-4DAF-AD8D-5914DCA5D55F Q27320822-32DA331E-ABB9-4D2C-9214-EE3ED54BF228 Q27347838-5FEBC0FD-BCEC-4351-916B-1DB0171994DC Q27469080-A5681FE2-E46E-4BAC-8580-0EDECF371DE1 Q27477620-43106ED6-D439-4346-8089-DC3FC431E4E2 Q27478174-2C1BB2A3-92A6-4D05-93F0-3936B2C26E96 Q27478188-D09D3F06-16EE-46A8-A6A5-2BBE0F659CF9 Q27480362-E9B7BD3C-C62F-4001-B21D-1CF48404C224 Q27480934-4C7BDA8A-0E57-4462-B91A-E0B166C48A99 Q27481398-C5E9A3C2-4FB5-41C3-977D-894FBA02F4F4 Q27485012-F8DC22F4-67BF-43B1-B31C-2A34476E774E Q27485447-2051D71A-4465-4AFC-85E4-86CE464D39AF Q27486041-871AE138-D402-4A43-BF49-7A3B9ED19EF3 Q27486525-7BA79E55-F901-4918-9944-4717AC053CF8 Q27486784-7187FC10-6398-4ECF-8D75-1CFBDD5B3C30 Q27486923-7EE9E942-176F-4AA4-B30C-2FF78FD343AF Q27486986-3BFB016A-CCB4-4615-86F4-E77F06E54892 Q27487399-A7A0E40B-5B3A-4560-90D7-8F708197E963 Q27487549-8291C6F1-F961-447C-9B25-313FB1E662C4 Q27487558-E3708C1C-C6E8-46C8-91F0-725C0F3C6731 Q27488999-7B0CA06D-ABF7-42C5-A1B8-331B38C3EA65 Q27489056-489EE6F1-765B-4230-8AE8-D9E2D2419B48 Q27489242-BC773D5A-1C13-40DD-B240-6D724BF90C0A Q27490248-4207FF30-23E5-4B5C-B704-AF36ECF90537 Q27490474-60D6501A-4CA0-4AF9-BDEF-34401249B61B Q27490501-42FC7AD7-07AE-499C-A3CF-EE4ABD677AFC

P2860

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

http://www.wikidata.org/entity/Q27473044

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Association between Hepatitis ...... in Iodixanol Density Gradients

@ast

Association between Hepatitis ...... in Iodixanol Density Gradients

@en

Association between Hepatitis ...... in Iodixanol Density Gradients

@nl

type

label

Association between Hepatitis ...... in Iodixanol Density Gradients

@ast

Association between Hepatitis ...... in Iodixanol Density Gradients

@en

Association between Hepatitis ...... in Iodixanol Density Gradients

@nl

prefLabel

Association between Hepatitis ...... in Iodixanol Density Gradients

@ast

Association between Hepatitis ...... in Iodixanol Density Gradients

@en

Association between Hepatitis ...... in Iodixanol Density Gradients

@nl

P1433

Q27473044-CB68D301-93B2-4DD0-9CC7-20BF39D11314

P1476

Q27473044-44012DF4-C37C-4965-88C1-83BCB1E457C5

P2093

Q27473044-1A14562E-1BD0-4257-99D8-B61A2B9139F0

Q27473044-3210E1E3-EBDE-4134-9BB7-C329F100CD34

Q27473044-39DAF34F-6910-4A6D-879A-8655234A0803

Q27473044-3A437DB7-2BB2-4CE6-9DB6-54792D561C5E

Q27473044-8B0FCB9B-00E7-482C-AC86-9D4BBEE70365

P2860

Q27473044-087BC8F9-4846-4996-B614-7A5D412349E4

Q27473044-08DB91A2-4CE0-46A4-AB9C-97F5627AED03

Q27473044-0EB51478-F6B8-4262-8619-85B614DE992C

Q27473044-14F00AD2-C00D-455F-AC38-C21EAC0CA33F

Q27473044-158C568B-2E88-4F6A-990A-9D710DCE9AD3

Q27473044-2356182B-F06D-4629-AEDE-89A130B121ED

Q27473044-25F640BE-3061-4E89-A4C2-A67B469FA0CF

Q27473044-2729A4C3-2D25-48A6-95B5-2E9B9097D43F

Q27473044-2A3E4873-A8C4-4EC8-90CA-CF010F539A39

Q27473044-2BE8C3AB-DCFA-473E-AEAD-6E3F7816A00E

P304

Q27473044-5653BB21-365B-4AF9-A0E9-C3D10A873B28

P31

Q27473044-E59429A5-7C09-4752-8998-DE098843F410

P3181

Q27473044-76E06E16-BE86-4E9C-96BF-65CF0946FBF2

P356

Q27473044-86D86771-34F4-4667-BB59-335A63CDF57F

P433

Q27473044-0599DB7C-BBD3-45C3-AEB5-C6C04C64AE37

P478

Q27473044-6704DE73-7341-48F6-AD8D-7706CD5641FF

P50

Q27473044-6AFB1261-5836-48F3-97C8-1E32F4640E72

P577

Q27473044-F1022865-11DD-4035-BED3-37659F4D1F57

P698

Q27473044-E90094CB-B72C-4911-90F0-C7607B5DE6C6

P921

Q27473044-5E254B16-10D8-46F2-B642-251A64C4238C

Q27473044-706D7B40-FB16-49DD-9279-1AD38B619FB1

P932

Q27473044-DC9422D5-619F-4B63-8044-D9651788474A

P3181

P356

JVI.80.5.2418-2428.2006

P1433

Journal of Virology

P1476

Association between hepatitis ...... in iodixanol density gradients

@en

P2093

Caroline Martin

http://www.w3.org/2001/XMLSchema#string

Geoffrey L Toms

http://www.w3.org/2001/XMLSchema#string

Margaret F Bassendine

http://www.w3.org/2001/XMLSchema#string

Søren U Nielsen

http://www.w3.org/2001/XMLSchema#string

Wanna Pumeechockchai

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of flaviviruses

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.

Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

P304

2418-2428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

866184

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.80.5.2418-2428.2006

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Alastair D. Burt

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16474148

http://www.w3.org/2001/XMLSchema#string

P921

P932

1395398

http://www.w3.org/2001/XMLSchema#string